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Abstract
Differentiation signaling results in reprogramming of cellular gene expression that leads to morphological changes and
functional specialization of a precursor cell. This global change in gene expression involves temporal regulation of
differentiation-specific genes that are located throughout the genome, raising the idea that genome structure may also be
re-organized during cell differentiation to facilitate regulated gene expression. Using in vitro adipocyte differentiation as a
model, we explored whether gene organization within the nucleus is altered upon exposure of precursor cells to signaling
molecules that induce adipogenesis. The peroxisome proliferator-activated receptor gamma (PPARc) nuclear hormone
receptor is a master determinant of adipogenesis and is required for adipose differentiation. We utilized the chromosome
conformation capture (3C) assay to determine whether the position of the PPARc locus relative to other adipogenic genes is
changed during differentiation. We report that the PPARc2 promoter is transiently positioned in proximity to the promoters
of genes encoding adipokines and lipid droplet associated proteins at 6 hours post-differentiation, a time that precedes
expression of any of these genes. In contrast, the PPARc2 promoter was not in proximity to the EF1a promoter, which drives
expression of a constitutively active, housekeeping gene that encodes a translation elongation factor, nor was the PPARc2
promoter in proximity to the promoter driving the expression of the C/EBPa regulatory protein. The formation of the long-
range, intergenic interactions involving the PPARc2 promoter required the regulatory factor C/EBPb, elevated cyclic AMP
(cAMP) levels, and protein kinase A (PKA) signaling. We conclude that genome organization is dynamically remodeled in
response to adipogenic signaling, and we speculate that these transient inter-genic interactions may be formed for the
purposes of selecting some of the transcriptionally silent tissue-specific loci for subsequent transcriptional activation.
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Introduction
Maturation of a pre-adipocyte into a mature adipocyte involves
significant changes in cellular structure and organization. Major
changes in the expression of cytoskeletal structural proteins occur
during adipogenesis of both cultured and primary cells; these
changes have been linked to the notable transformation in cell
morphology that occurs when preadipocytes differentiate into
adipocytes [1–3]. Recent studies also report structural alterations
that occur in the nuclear lamina and in the connections between
the nucleus and cytoplasmic filaments as a function of adipogenic
differentiation [4]. Furthermore, expression of the lamin associ-
ated polypeptide 2a (LAP2a) or reduction in the expression of
lamins or of the lamin associated protein emerin modulates
adipocyte differentiation [5–7], while mutations in nuclear lamina
proteins have been associated with lipodystrophy syndromes [8,9].
Other reports document organizational changes within the
nucleus. These include reports of differentiation-dependent
changes in chromosome territories [10], relocalization of adipo-
genic gene positioning within the nucleus relative to the nuclear
lamina during differentiation [11,12], and preferential association
with SC-35 domains [13], which are nuclear structures that are
enriched in factors involved in pre-mRNA metabolism and that
may act to spatially link gene expression and mRNA processing
[14,15].
The pivotal controller of adipogenesis is PPARc2, which is both
necessary and sufficient for adipogenic differentiation [16–18].
While PPARc2 expression does not occur until an intermediate
stage in the differentiation program [19], it is well-established that
the PPARc2 promoter is marked by early binding of C/EBPb and
early changes in histone modification patterns and DNase I
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hypersensitivity [20–23] well in advance of PPARc2 expression.
This suggests the possibility that the early modulation of factor
binding and chromatin structure at the PPARc2 promoter may
serve as a focal point for differentiation-dependent changes in
higher order chromatin structure. Given these considerations, we
wondered whether there was any spatial relationship between the
PPARc2 locus and the loci encoding other genes expressed during
adipogenesis.
Most adipocyte-specific gene expression involves regulation by
PPARc2 [24]. PPARc2 target genes are diverse and include genes
encoding adipokines, which are hormones secreted by adipose that
contribute to the regulation of energy balance of the organism and
guide a number of physiological and pathological processes
[25,26]. Classic adipokines include adiponectin and leptin.
Adiponectin levels are directly correlated with insulin sensitivity.
Leptin is an appetite-sensitizing hormone for providing feedback
for satiety, and both adipokines are believed to have high
therapeutic potential [27,28]. Another class of PPARc2 target
genes mediates lipid accumulation and storage. Lipid droplets are
coated in proteins called perilipins, including perilipin 1 and
adipose differentiation-related protein (ADRP), also called perili-
pin 2, which serve to protect the lipids contained within from
adipose lipases [29,30].
In this study, we document interactions between the PPARc2
promoter and the promoters controlling the adipocyte hormone
genes and perilipins 1 and 2 in differentiating 3T3-L1 adipocytes
and in differentiating C3H10T1/2 mesenchymal cells using the
chromosome conformation capture (3C) assay. Interestingly, the
observed interactions between the PPARc2 promoter and
adipokine and perilipin promoters were most frequent at 6 hr
following the addition of the adipogenic cocktail and decreased
significantly at later time points. Thus the formation of these inter-
genic interactions involving the PPARc2 promoter preceded
PPARc2 gene expression and PPARc2 target gene expression.
Interactions were dependent upon the C/EBPb transcriptional
regulator. Additional experiments revealed that cAMP signaling
was required for the formation of these long-range, inter-genic
interactions, and that these interactions were also dependent on
elevated cAMP levels and on the presence of protein kinase A.
Materials and Methods
Cell Culture and Retroviral Infections
3T3-L1 pre-adipocyte cells and C3H10T1/2 mesenchymal cells
were obtained from ATCC and cultured in Dulbecco’s modified
Eagle’s medium (DMEM) containing 10% calf serum or 10% fetal
calf serum (FCS). For adipogenic differentiation, 2 day post-
confluent cells were differentiated with a standard adipogenic
cocktail (1 mg/ml insulin, 0.25 mg/ml dexamethasone, 0.5 mM
isobutylmethylxanthine (IBMX) with 10% FCS) or with the
indicated subset of components. Where indicated, forskolin
(10 mM, Calbiochem) was added to serum-containing differenti-
ation media lacking the differentiation cocktail components for the
first two days of the differentiation process. 3T3-L1 cells were also
pre-treated for 1 hour prior to administration of differentiation
cocktail with either 10 mM H89 (Sigma) or 10 mM myr-PKI
(Calbiochem). BOSC23 retroviral packaging cells were cultured in
DMEM containing 10% FCS and were cycled through selective
media every 1–2 months as described [31]. pSuperior-retro-puro
(OligoEngine, Seattle, WA), pSuperior-retro-puro-PKAC1a, pSu-
perior-retro-puro-PKAC1b, and pSuperior-retro-puro-C/EBPb
[23] viral packaging was achieved by transfection of the plasmid
into BOSC23 cells using Fugene6 (Roche) as described [23].
Collection of viral supernatant and infection of cells was also
described previously [23].
Chromatin Conformation Capture (3C) Assay
The 3C protocol was adapted from published methods [32–34].
Cells were cross-linked with 1% formaldehyde for 10 minutes at
RT and quenched with 0.125M glycine for 5 min. Samples were
harvested in PBS containing protease inhibitor cocktail (Sigma).
Pellets were lysed in lysis buffer (10 mM Tris HCI pH 8.0, 10 mM
NaCl, 0.5% Nonidet P-40) containing protease inhibitors,
incubated on ice for 15 min, and dounced 10 times using pestle
B, followed by another 15 minute incubation on ice. After removal
of supernatant, nuclei pellets were re-suspended in restriction
endonuclease buffer 2 (NEB; 50 mM NaCl,10 mM Tris-
HCl,10 mM MgCl2,1 mM Dithiothreitol) and washed once in
NEB buffer 2. SDS was added to a final concentration of 0.3%,
followed by a 60 min incubation at 65 degrees C, followed by SDS
sequestration using 1.8% Triton X-100 for 60 minutes at 37
degrees C. Samples were incubated with 350 units each of
restriction enzymes StuI and PvuII (NEB) and were incubated
overnight at 37 degrees C. After SDS-mediated inactivation of the
enzymes for 30 minutes at 65uC (1.6% final concentration) and
SDS-sequestration with 1% Triton X-100 at 37 degrees C for
60 min, 2X Takara Mighty Mix was added to each sample and
incubated for 1 hr at 16 degrees C. Ligated samples were treated
overnight with proteinase K (20 mg/mL) and RNase A (10 mg/
mL), and DNA fragments were purified with a DNeasy Blood and
Tissue kit (Qiagen). Samples were analyzed by realtime PCR using
the Promega GoTaq Master Mix on a DNA Opticon (MJ
Research) or an ABI StepOne Plus (Applied Biosystems) and
interaction frequencies were normalized to the values of intra-
genic interactions occurring at the endogenous TFIIH (ERCC3)
locus [35] or a gene desert region located on chromosome 3 [36].
Primer Sequences for 3C Assays
PPARc2 promoter StuI site 1 (2132 bp from TSS) forward: 59-
GTAATGTACCAAGTCTTGCCAAAGCAGCAG
Leptin PvuII Forward: 59-TCACAGGATGAAATGAGAC-
GACTGTTCTTCG
Adiponectin PvuII Forward: 59-TAGAGAATGGC-
CAAAGCCTGGAAACAGGA
Perilipin-1 PvuII Forward: 59-TGTTTCTGAGGAGGA-
GACCTT
Perilipin-2 PvuII Forward: 59-AATGAGTGGCCCCA-
GAGTC
C/EBPa StuI Forward: 59- CTAGGTTGCTGGTCCAAAG-
CAGTCTCCAAC
EF1a StuI Forward: 59-GTCGCCTTGGACGTTCTTTT
ERCC3 20.9 Forward: 59-TGTAGTTCTGTGGCTA-
GAACCTG
ERCC3 3.7 Forward: 59-TGATGCAGAAGGATGCTGAC
Chromosome 3 Gene desert region:
GDR StuI Forward 59-CCATTTAGAATCGTGGCAGGTC-
TAT
GDR PvuII Forward 59-ATACATTGAAATGAGTCCTCCA-
CAT
Protein Extracts and Western Blots
Whole cell extracts were prepared and quantified and used for
western blotting as described [37]. Primary antibodies were
PKAC1a (Santa Cruz; sc-903), PKAC1b (Santa Cruz: sc-904), C/
EBPb (Santa Cruz: sc-150), and p85 phosphatidylinositol-3-kinase
(Millipore: 06–195).
PPARc Locus and Long-Range Chromatin Interactions
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Figure 1. The PPARc2 promoter maximally interacts with adipokine and perilipin gene promoters in 3T3-L1 cells 6 hours post-
differentiation. (A) Schematic map of chromosomal locations of loci of interest. Lep: leptin; Plin1: perilipin 1; Plin2: perilipin 2; Eef1a1: EF1a; AdipoQ;
adiponectin. 3C assays were performed at the indicated times to measure long-range, intergenic interactions between the PPARc2 promoter and (B)
the adiponectin promoter, (C) the leptin promoter, (D) the perilipin 1 promoter, (E) the perilipin 2/ADRP promoter, (F) the C/EBPa promoter, or (G) the
EF1a promoter. Interaction frequencies are presented relative to the intragenic interaction frequency observed between different regions of the TFIIH
locus, which served as a normalization control. The interaction frequency at 0 h was set to 1; the interaction frequencies for the remaining time points
are presented relative to that value. Results indicate the average of three independent experiments +/2 standard deviation. Values for the timepoint
of maximum interaction frequency (6 h) were compared to values at time 0 by one-tailed t-test. ***p,0.001.
doi:10.1371/journal.pone.0086140.g001
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Statistics
Results are indicated as the average of three independent
experiments +/2 standard deviation. Data were statistically
analyzed by a one-tailed t-test.
Results
The PPARc2 Promoter Makes Long-range Interactions
with Adipokine and Perilipin Promoters in Differentiating
Adipocytes
Numerous molecular changes occur at the PPARc2 promoter
within hours following the onset of adipogenic differentiation
signaling. Restriction endonuclease accessibility is increased within
30 minutes, c-fos binds within 1 hour, C/EBPb binds within 2
hours, and DNAse I hypersensitivity was reported by 2 hours
[21,23]. All of these events occur well before the onset of PPARc2
mRNA synthesis [38].
We hypothesized that the onset of differentiation signaling
might cause rearrangement of genomic chromatin structure.
Because of the requirement for and central role of the PPARc2
protein in the adipogenic differentiation process, we investigated
whether the PPARc locus might be a region where changes in
genomic organization occur. We utilized 3C methodology [32] to
assess relative changes in gene organization. The 3C technique
utilizes cross-linking to identify regions of chromatin that are in
close juxtaposition to each other and has allowed identification of
inter-chromosomal interactions as well as long-range interactions
between non-contiguous sequences on the same chromosome [39–
41].
For initial 3C experiments, we sought to determine whether the
PPARc locus is in close physical proximity to other adipogenic loci
in undifferentiated pre-adipocytes or in pre-adipocytes that have
been exposed to differentiation signaling. We designed primers to
the PPARc2 promoter and to promoters from four known
PPARc2 target genes, those controlling expression of the
Figure 2. The PPARc2 promoter maximally interacts with adipokine and perilipin gene promoters in C3H10T1/2 cells 6 hours post-
differentiation. 3C assays were performed at the indicated times to measure long-range, intergenic interactions between the PPARc2 promoter
and (A) the adiponectin promoter, (B) the leptin promoter, (C) the perilipin 1 promoter, (D) the perilipin 2/ADRP promoter, (E) the C/EBPa promoter,
or (F) the EF1a promoter. Interaction frequencies are presented relative to the intragenic interaction frequency observed between different regions of
the TFIIH locus, which served as a normalization control. The interaction frequency at 0 h was set to 1; the interaction frequencies for the remaining
time points are presented relative to that value. Results indicate the average of three independent experiments +/2 standard deviation. Values for
the timepoint of maximum interaction frequency (6 h) were compared to values at time 0 by one-tailed t-test. ***p,0.001; **p,0.01.
doi:10.1371/journal.pone.0086140.g002
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adipokines, leptin and adiponectin, and those regulating the
expression of two genes involved in lipid metabolism and storage,
perilipin 1 and perilipin 2/ADRP. We also decided to test for
interactions between the PPARc2 promoter and the C/EBPa
promoter, which is not bound by PPARc2 but is regulated by
PPARc2 protein via displacement of co-repressor proteins [42].
Finally we examined interactions between the PPARc2 promoter
and the promoter of the EF1a gene, which is a constitutively active
housekeeping gene encoding the eukaryotic translation initiation
factor 1 alpha 1. The 3C assay is limited by the choice of
restriction sites within range of the promoter, so we took
advantage of a StuI restriction site within 150 bp of the
transcription start site (TSS) of PPARc2 and thus could assess
interactions between genomic sites cut with Stu I and with PvuII,
another blunt end cutter. The PPARc locus is in band 6qE3
whereas the leptin locus is situated at 6qA3.3 on chromosome 6,
85 Mbp away. The adiponectin locus is located on chromosome
16, while the perilipin 1 and perilipin 2/ADRP loci are located at
chromosomes 7 (7qD2) and 4, respectively. The C/EBPa and the
EF1a loci are located on chromosomes 7 (7qB1) and 9,
respectively (Fig. 1A). Thus any interactions observed would be
long-range within the same chromosome or would be inter-
chromosomal.
Initial experiments were performed as a time course using 2-day
confluent 3T3-L1 preadipocytes (time 0) and cells treated with the
standard adipogenic differentiation cocktail of insulin, dexameth-
asone, and IBMX for the indicated number of hours. Interaction
frequencies were normalized to the interaction frequencies
observed in each sample for TFIIH locus interactions, and were
presented as relative values with the frequency observed at time 0
set to 1. The results indicate a spike in interaction frequency
between the PPARc2 promoter and the adiponectin promoter at 6
hours post-differentiation, which precedes PPARc2 gene expres-
sion, with interaction frequencies at 24 and 48 hours greatly
reduced in comparison to the 6 hour timepoint (Fig. 1B). Nearly
identical results were observed for the interaction frequency
between the PPARc2 promoter and the leptin promoter (Fig. 1C).
Interaction frequencies between the PPARc2 promoter and the
perilipin 1 and perilipin 2/ADRP promoters showed a similar
result (Fig. 1D–E), though the relative interaction frequencies for
these promoters was reduced by ,40–60%. In contrast, interac-
tions between the PPARc2 and C/EBPa promoters were minimal
(Fig. 1F). Interactions between the PPARc2 promoter and the
constitutively active EF1a promoter were also at background level
(Fig. 1G). The temporal nature of the interactions between the
PPARc2 promoter and the two adipokine and the two lipid
droplet associated protein gene promoters, along with the lack of
interactions between the PPARc2 promoter and the C/EBPa or
EF1a promoters, indicates a level of specificity for the observed
long-range genomic interactions.
The data in Figure 1 and in all subsequent figures were
normalized to interaction frequencies detected by 3C at the TFIIH
locus. The TFIIH locus was chosen to control for interactions
because it exhibits a specific three-dimensional structure that
appears to be invariant between different cell types and under
different conditions. Thus the interaction frequency between
sequences from different parts of the TFIIH locus are expected to
be equivalent in all samples and can be used to control for sample
to sample variation, as previously demonstrated [35]. As an
additional control, we normalized the data in Figure 1 to the
interaction frequency determined by 3C analysis of a gene desert
region on chromosome 3, as done by others [36]. The data
obtained by normalization to the interaction frequencies detected
at the gene desert region is indistinguishable from the data
normalized to TFIIH locus interactions (Fig. S1).
To confirm the results, we utilized a different cellular model for
adipocyte differentiation. C3H10T1/2 cells are mesenchymal
precursor cells that are capable of differentiating along the
adipocyte lineage in response to the same cocktail used to induce
3T3-L1 cell differentiation [43]. The promoters for the adipokines
as well as the perilipin genes associated with the PPARc2
promoter maximally at the 6 hr timepoint (Fig. 2A–D), while
interactions with the C/EBPa and EF1a promoters were minimal
(Fig. 2E–F). The relative interaction frequencies between inter-
acting promoters in the differentiating C3H10T1/2 cells were
lower than those observed in the 3T3-L1 cells. The reason(s) for
these differences is not known, though it is unrelated to the
efficiency of differentiation, as Oil Red O staining of plates of both
cell types maintained in differentiation conditions for 4 days
showed equivalent levels of Oil Red O stained cells (data not
shown).
Long-range Inter-genic Interactions Involving the
PPARc2 Promoter Require C/EBPb
C/EBPb is a critical regulator of adipogenesis, factoring into the
activation of both C/EBPa and PPARc2 gene expression, which
are essential for adipogenic differentiation [44,45]. Since C/EBPb
binds to the PPARc2 promoter within the first 2 hours of
differentiation and is required to maintain open chromatin
structure at the PPARc2 promoter [23,46], we asked whether
C/EBPb was similarly required for the long-range chromatin
interactions involving the PPARc2 locus at 6 h post-differentia-
tion. 3T3-L1 cells were infected with retrovirus expressing a
control shRNA or shRNA previously shown to reduce C/EBPb
levels [23] and subsequently differentiated for 6 h. As indicated in
Fig. 3A–E, the interaction frequency for PPARc2 with each of its
interacting loci was almost completely eliminated. Control western
blots demonstrated that C/EBPb protein levels were reduced in
cells expressing the shRNA against C/EBPb (Fig. 3F). These
results suggest that C/EBPb and the initial events that occur in the
first few hours of PPARc2-driven gene activation during
adipogenesis are required for subsequent formation of long-range
chromatin interactions involving the PPARc2 locus.
Figure 3. C/EBPb is required for the formation of long-range, inter-genic interactions between the PPARc2 promoter and the
indicated promoters. Cells exposed to control shRNA or shRNA targeting C/EBPb were assayed at 0 h and 6 h post-differentiation. Interaction
frequencies between the PPARc2 promoter and (A) the adiponectin promoter, (B) the leptin promoter, (C) the perilipin 1 promoter, (D) the perilipin 2/
ADRP promoter, or (E) the EF1a promoter are presented relative to the intragenic interaction frequency observed between different regions of the
TFIIH locus, which served as a normalization control. The interaction frequency at 0 h in the control shRNA treated cells was set to 1; the interaction
frequencies for the other samples are presented relative to that value. Results indicate the average of three independent experiments +/2 standard
deviation. Values for the 6 h control shRNA treated samples were compared to values for the samples treated with C/EBPb shRNA by one-tailed t-test.
***p,0.001. (F) Western blots indicating C/EBPb protein levels in control and C/EBPb shRNA treated cells. PI-3 kinase levels were monitored as a
loading control.
doi:10.1371/journal.pone.0086140.g003
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Long-range Inter-genic Interactions Involving the
PPARc2 Promoter Require PKA Signaling
The cocktail used to induce differentiation contains activators of
different signaling pathways. These include dexamethasone, a
synthetic glucocorticoid agonist, IBMX, a phosphodiesterase
inhibitor that elevates cellular cAMP levels, and insulin, a well-
known modulator of glucose uptake. To determine whether one or
more of these signaling molecules were required for the formation
of interactions between the PPARc2 promoter and the other
promoters, we performed a series of dropout experiments where a
series of differentiation cocktails, each lacking one component,
were used to stimulate differentiation. Cocktails lacking dexa-
methasone or insulin had no effect on the interaction frequencies
observed between the PPARc2 promoter and the adipokine and
the perilipin promoters 6 hours post-differentiation (Fig. 4). As
expected under these conditions, adipogenic differentiation was
inhibited (data not shown). However, removal of IBMX blocked
the formation of the long-range inter- and intra-genic interactions
at this time point (Fig. 4), along with differentiation into mature
adipocytes.
Since IBMX was necessary for the formation of the interactions
between PPARc2 and the other gene promoters, we next decided
to test whether IBMX was sufficient to form the interactions. 3C
assays were performed on 3T3-L1 cells following 6 hours of
exposure to the complete cocktail or to each of the signaling
components alone. Neither insulin alone nor dexamethasone alone
supported the formation of the observed long-range interactions
whereas exposure to IBMX alone did support the formation of the
interactions between the PPARc2 and the adipokine and perilipin
promoters (Fig. 5). Since IBMX elevates cAMP levels, we sought
to confirm that cAMP elevation was sufficient to promote
intergenic interactions. Exposure of 3T3-L1 cells to serum-
containing media containing forskolin, an activator of adenylyl
cyclase [47], but lacking the other differentiation cocktail
components promoted interactions between PPARc2 and the
adipokine and perilipin promoters 6 hours later (Fig. 5). Collec-
tively, these findings indicate that that enhanced cAMP levels are
critical for the formation of the long-range interactions between
PPARc2 and other adipogenic genes.
The cAMP-dependent protein kinase, also known as protein
kinase A (PKA), is activated by elevated levels of cAMP. PKA
consists of a tetrameric holoenzyme [48] that contains two
catalytic subunits, Ca and Cb [49]. To assess the requirement
for PKA in the formation of the long-range genomic interactions
involving the PPARc2 promoter, we inhibited PKA activity by
treating cells with PKI, a competitive, synthetic peptide inhibitor
of PKA derived from the active domain of the naturally occurring
PKA inhibitory protein also called PKI [50], or with H89, an
isoquinolinesulfonamide selected for potent and specific PKA
inhibition [51]. PKA inhibition by either compound inhibited
long-range interactions between PPARc2 promoter and the
perilipin, leptin, and adiponectin promoters (Fig. 6). These
experiments demonstrate the requirement for PKA in mediating
long-range chromatin interactions involving the PPARc2 promot-
er.
To directly determine whether PKA is involved in the formation
of long-range interactions between the PPARc2 and PPARc2-
target gene promoters, we used shRNAs against either the Ca or
Figure 4. Elevation of cAMP levels is required for the formation
of long-range, inter-genic interactions between the PPARc2
promoter and the indicated promoters. The EF1a promoter is
shown as a control. 3C assays were performed on 3T3-L1 cells at 0 or at
6 h post-differentiation in the presence of complete differentiation
cocktail or in cocktail lacking the indicated component. Interaction
frequencies were quantified as described in the legends for Figures 1–2.
Results indicate the average of three independent experiments +/2
standard deviation. Values for the 6 h samples differentiated in
complete cocktail were compared to values for the samples differen-
tiated in cocktail lacking IBMX by one-tailed t-test. p values are
indicated on the graph. ins; insulin. dex; dexamethasone.
doi:10.1371/journal.pone.0086140.g004
PPARc Locus and Long-Range Chromatin Interactions
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Figure 5. Elevation of cAMP levels is sufficient for the
formation of long-range, inter-genic interactions between the
PPARc2 promoter and promoters. The EF1a promoter is shown as
a control. 3C assays were performed on 3T3-L1 cells at 0 or at 6 h post-
differentiation in the presence of complete differentiation cocktail or in
serum-containing media containing only the indicated component.
Interaction frequencies were quantified as described in the legends for
Figures 1–2. Results indicate the average of three independent
experiments +/2 standard deviation. Values for the 6 h samples
differentiated in complete cocktail were compared to values for the
samples differentiated for 6 h in cocktail containing serum and IBMX or
serum and forskolin by one-tailed t-test. ***p,0.001; **p,0.01. ins;
insulin. dex; dexamethasone.
doi:10.1371/journal.pone.0086140.g005
Figure 6. PKA inhibitors prevent the formation of long-range,
inter-genic interactions between the PPARc2 promoter and (A)
the adiponectin promoter, (B) the leptin promoter, (C) the
perilipin 1 promoter, (D) the perilipin 2/ADRP promoter. The
EF1a promoter (E) is shown as a control. Interaction frequencies were
quantified as described in the legends for Figures 1–2. Results indicate
the average of three independent experiments +/2 standard deviation.
Values for the 6 h samples differentiated in complete cocktail were
compared to values for the samples differentiated for 6 h in complete
cocktail containing the PKI or H89 inhibitors by one-tailed t-test.
***p,0.001.
doi:10.1371/journal.pone.0086140.g006
PPARc Locus and Long-Range Chromatin Interactions
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Figure 7. PKA is required for the formation of long-range, inter-genic interactions between the PPARc2 promoter and (A) the
adiponectin promoter, (B) the leptin promoter, (C) the perilipin 1 promoter, (D) the perilipin 2/ADRP promoter. The EF1a promoter (E)
is shown as a control. 3T3-L1 cells infected with retroviral vectors expressing control shRNA or shRNA targeting the PKA-Ca or PKA-Cb subunits were
generated (see Methods). 3C assays were performed on these cells at 0 or at 6 h post-differentiation in the presence of complete differentiation
cocktail. Interaction frequencies were quantified as described in the legends for Figures 1–2. Results indicate the average of three independent
experiments +/2 standard deviation. Values for the 6 h samples treated with control shRNA were compared to values for the 6 h samples treated
with PKA-Ca or PKA-Cb shRNA by one-tailed t-test. **p,0.01. (F) Oil Red O staining of infected 3T3-L1 cells allowed to differentiate for 4 days. (G)
Western blots indicating the levels of the PKA-Ca or PKA-Cb subunits in the infected cells. PI-3K levels were monitored as a loading control.
doi:10.1371/journal.pone.0086140.g007
PPARc Locus and Long-Range Chromatin Interactions
PLOS ONE | www.plosone.org 9 January 2014 | Volume 9 | Issue 1 | e86140
Cb subunit to reduce PKA protein levels in 3T3-L1 pre-
adipocytes. Previously we demonstrated that knockdown of either
catalytic subunit blocked 3T3-L1 cell differentiation, in part
because chromatin accessibility changes at the PPARc2 promoter
were inhibited [23]. Knockdown of either subunit inhibited inter-
chromosomal interactions between the PPARc2 promoter and the
adiponectin and the perilipin promoters along with the intra-
chromosomal interaction between the PPARc2 promoter and the
leptin promoter (Figure 7A–E). Oil Red O staining confirmed that
knockdown of the PKA catalytic subunit inhibited differentiation
and western blotting demonstrated that the PKA catalytic subunit
protein levels were, in fact, reduced (Figure 7F–G). We conclude
that PKA is required for PPARc2 promoter involvement in long-
range interactions with other promoters.
Discussion
In this study, we provide evidence that long-range chromatin
interactions occur between the promoter controlling the expres-
sion of the master regulator of adipogenesis, PPARc2, and
promoters controlling the expression of adipokines and lipid-
droplet associated proteins in a transient manner that requires C/
EBPb and protein kinase A prior to the onset of the expression of
these genes. While we do not understand the functional
ramifications of such associations, we speculate that they may
relate to early events in adipogenesis that prepare or mark tissue-
specific loci for subsequent gene activation.
Cytological evidence supports the idea of chromosomal domains
in interphase cells, however, the relative positions of chromosomal
domains can vary by cell type and by the activation of signaling
and/or gene induction pathways [52,53]. The interfaces between
chromosomal domains provide an environment in which inter-
chromosomal interactions may form. Inter-chromosomal interac-
tions have been documented previously. Such associations have
often been correlated with the regulation of gene expression [54–
61]. The transient nature of the observed long-range interactions
suggests that if the interactions are part of the process through
which gene activation is initiated, they could reflect the
localization of the regulatory sequences with machinery that
modifies the local chromatin structure. Obvious candidates for
such machinery would be enzymes that post-translationally modify
the promoter histones. Alternatively, or in addition, promoter
sequences could have nucleosomal composition altered by
addition or removal of histone variants, linker histones, or non-
histone chromatin proteins. Recent work has suggested that
deposition of the variant histone H3.3 marks skeletal muscle-
specific genes for activation in myoblasts even before differenti-
ation is initiated [62]. Precise time course experiments would be
required to determine whether H3.3 deposition or the addition or
removal of any histone or histone modification tracks with the
formation of long-range interactions between the PPARc2 and
other promoters. This model hypothesizes that the enzymatic
modifications occur at one or more specific sites in the nucleus.
Determining whether such a site corresponds to a recognizable
nuclear domain (e.g. – PML body, splicing speckle) or not would
require immuno-FISH or similar approaches. Regardless, if fixed
sites of enzymatic modification of genomic DNA exist, it would
necessitate localization of the promoter sequences to that site. The
transient nature of the interactions between the adipogenic gene
promoters would then suggest that any chromatin modifications or
structural changes that were made would be reasonably stable and
not subjected to a dynamic cycle of addition/removal of the
specific mark and/or histone. Whether the observed inter-genic
associations relate to the formation or maintenance of transcrip-
tion factories, where multiple genes are co-localized with pol II
and active transcription [63–65], requires additional investigation.
The possibility of a link between the promoter interactions
between PPARc2 and the selected adipokine and perilipin genes
and functions related to subsequent adipocyte-specific gene
expression is further complicated by the selectivity of the
interactions that were observed. The relative interaction frequen-
cies observed between PPARc2 and the C/EBPa promoter were
minimal and equivalent to those observed between the PPARc2
and EF1a promoters, which represent background levels. Clearly,
the C/EBPa gene is activated during adipogenesis, yet unlike the
other gene promoters examined, regulation of C/EBPa expression
by PPARc2 seems to be limited to post-transcriptional regulation
in which the PPARc2 protein functions to release HDAC1 from
the C/EBPa promoter as part of the activation process [42].
Analyses of ChIP-seq data from 3T3-L1 cells and adipose tissue do
not reveal significant binding of PPARc2 or C/EBPa in the
proximal promoter region of the C/EBPa gene [66,67]. Perhaps
different mechanisms occur for controlling the organization and
activation of the C/EBPa gene during differentiation. Alterna-
tively, perhaps C/EBPa participates in similar interactions with
other adipogenic genes, but gene associations involving the C/
EBPa promoter do not overlap with interactions involving the
PPARc2 locus. These possibilities remain to be tested; a more
genome-wide approach would likely be more productive than the
candidate gene approach taken here.
Regardless of the functional consequences of these long-range
interactions, their existence raises the interesting question of how
genomic DNA ‘‘moves’’ around the nucleus. The concept of rapid
repositioning of genomic sequences is controversial. There are
previous reports in the literature indicating that rapid, locus-
specific genomic rearrangements occur [55,68,69]. Interestingly,
the movement of the loci analyzed has been linked to the activity
of nuclear actin and myosin as well as to dynein light chain
[55,68]. However, the reported rapid repositioning of estrogen-
responsive genes upon estrogen treatment [55] has been
questioned [70], and other work indicates that movement of
chromosome territories is limited during interphase [71,72].
Clearly there is a need for substantial additional work to better
understand the dynamics of locus-specific chromatin organization
and re-organization during physiological processes such as cell
differentiation.
Figure 4, Figure 5, Figure 6, Figure 7 demonstrate that
formation of the long-range interactions required elevated cAMP
levels and the catalytic subunits of protein kinase A. Adipogenic
signaling in both the 3T3-L1 and the C3H10T1/2 cell culture
models requires addition of IBMX, which is a phosphodiesterase
inhibitor that elevates cellular cAMP levels, which in turn activates
PKA. During the early stages of adipogenic differentiation, PKA
phosphorylates CREB, the cAMP regulatory element-binding
protein, which contributes to the transcriptional activation of C/
EBPb [73,74], at least in part by binding to the C/EBPb promoter
within an hour of the induction of differentiation [73]. At the
PPARc2 promoter, chromatin accessibility and c-fos binding
occur within an hour of the induction of differentiation, and C/
EBPb binding occurs two hours post-differentiation. All of these
events are dependent on elevation of cAMP levels and PKA
function [23]. An additional intriguing finding is that PKA has the
potential to form a complex with dynein [75], which as previously
stated, was implicated as a molecular motor that is necessary for
gene-specific organizational changes in estrogen treated cells [55].
Thus a potential relationship between PKA and a factor linked to
genomic organization exists that might explain the observed
formation of long-range intergenic interactions between selected
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adipogenic promoters. Though the connections between PKA, C/
EBPb, the molecular events at the PPARc2 promoter, and the
involvement of the PPARc2 promoter in long-range intergenic
interactions require further clarification, it seems clear that
signaling through PKA is intricately involved in modulating the
gene organization and transcriptional potential of tissue-specific
gene expression during adipocyte differentiation.
Supporting Information
Figure S1 The PPARc2 promoter maximally interacts
with adipokine and perilipin gene promoters in 3T3-L1
cells 6 hours post-differentiation. 3C interaction frequencies
between PPARc2 and the indicated promoters that were
presented in Figure 1 were re-calculated based on normalization
to interaction frequencies measured in a gene desert region on
chromosome 3 [36] instead of to interaction frequencies measured
at the TFIIH locus. Results indicate the average of three
independent experiments +/2 standard deviation. Values for
the timepoint of maximum interaction frequency (6 h) were
compared to values at time 0 by one-tailed t-test. ***p,0.001.
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